SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

International Spirits & Wellness Holdings, Inc. (OTCMKTS:ISWH) should be seen as a textbook case example of a deep value opportunity. The idea with deep value is that the market has so completely lost sight of a stock that, even if the company starts to see tremendous success and tells the world about it loudly, no one seems to be listening.

But – and here’s the really important point – eventually, everyone hears it. Eventually, the tape starts to act in a manner that reflects the success story that the company has been telling for some time.

Taking a look at shares of ISWH stock, the first thing you see is a triple-zero sub-penny price per share. It’s hard to get past that idea no matter what else you find out about the company. However, in this case, we would encourage you to look at the rest of the story with an open mind. 

Why? Because, according to all reasonable analysis of all available data, the company will be profitable on a gross basis for three consecutive quarters by year end, on better than 100% sales growth on a sequential basis across three totally different lines of business.

And, perhaps more to the point, ISWH is doing business in highly scalable markets, which means these numbers could become enormous if that growth rate continues.


It’s a Whole New Thing!

One of those lines of business is the company’s CBD brand, which is now set for a branding refresh and a major attack on the marketplace. Part of that story, as we found out this morning, is a new partnership agreement with a major player. 

“While we cannot fully disclose the identity of the counterparty in this Agreement, we can state that this is a well-known, nationally respected firm that has in-house access to cutting edge technology and a competitive, nationwide marketing and distribution footprint,” stated Terry Williams, CEO of ISWH.

According to the release, this forthcoming agreement is for the appointment of ‘an exclusive manufacturing and marketing partner’ to handle the launch of five new CBD-based wellness products and a comprehensive branding refresh for the P19 CBD brand.

What do we know here? This looks like it will really be a comprehensive brand establishment process, with trademarks, custom digital branding landscapes with websites and storefronts, and social media footprints for all products and themes. And POP, POS sales & marketing guides to go along with each piece.

This may be just exactly what this story needs right now: a fresh start with a big marketing partner capable of nationwide reach and distribution.

Mr. Williams continued, “As soon as the Agreement is fully executed, we will disclose all facts involved. But, given where we know things stand at this point, we felt we had a responsibility to inform our shareholders and the broader marketplace that this deal was in the works and set for completion, and to begin to convey the dramatic impact that this will likely have on our operations going forward. This Agreement sets in motion a process that will put ISWH on the map in the CBD space on a significantly expanded scope and scale.”

If that last sentence is true, then this stock isn’t going to stay at $0.0003/share for much longer.

SHARE
Previous articleGeneral Electric Company’s (NYSE:GE) GE Healthcare Expands Portfolio For U.S. Radiologists And Patients With Clariscan™
Next articleArcadia Biosciences Inc (NASDAQ:RKDA) Gets First Wheat Purchase Commitment For 2020
Steve Kanaval: Portfolio Manager/Writer/ Market Analyst Steve began his career in the Trading Pits in Chicago making markets at the Chicago Mercantile Exchange (NYSE:CME) the Chicago Board of Trade and the CBOE in the early 80’s. He ran the Morgan Stanley Derivative Prop Trading for the firm specializing in Index Arbitrage. He continued his career as a Trader/Portfolio Manager for multiple Hedge Funds during the Internet Boom of the 90’s managing large portfolios. Steve is known as an expert in MicroCap Technology Stocks and the emerging Digital Currency markets as a Portfolio Manager for his Family Office. Steve has managed portfolio’s in volatile asset classes for 3 decades as a commodity trader, hedge fund manager and digital currency trader and miner. Steve publishes his views on the asset classes in a public forum and has published more than 10,000 articles simplifying these complex and volatile assets for readers. His work is published on multiple sites including Bloomberg, Equities.com, Hacked.com, CryptoCurrencyNews as a paid contributor. His work includes research, journalism and archived video on important market volatility related to stocks, digital currency and other volatile misunderstood asset classes. He offers a humorous, unique insight and the related back stories and drivers for readers interested in volatility and emerging market assets. Full disclosure Steve is long 25 digital currencies and sits on the board of multiple public companies involved in digital currencies, and owns shares in these companies from time to time.